Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 17Biliary Tract Neoplasms 4Pancreatic Neoplasms 3Adenocarcinoma 3Neoplasms 2Esophageal Neoplasms 2Cholangiocarcinoma 2Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic cancer, adult 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1NSCLC 1Locally Advanced Gastric or Gastroesophageal Junction Cancer 1Locally Advanced Gastric Cancer 1Klatskin Tumor 1Gastric Cancer Peritoneal Metastases 1Gastric Adenocarcinoma 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Chemotherapy Effect 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1

Interventions

bismuth tripotassium dicitrate 1S 1 (combination) 1Palliative Care 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy Effect × S 1 (combination) × 1 year × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡